| iPRR . | iPRR expression . | iPRR structure . | Signaling pathway . | Endogenous ligand . | Endogenous ligand expression . | Microbial ligand . | Activating receptor for the same ligand . |
|---|---|---|---|---|---|---|---|
| CD300a/f | Broad on immune cells, upregulated on activation | Ig-like | ITIM | PS, PE | Exposed in programmed cell death | — | Tim4 |
| CEACAM‑1 | Broad on immune, epithelial, and endothelial cells | Ig-like | ITIM | CEACAM1 and other CEACAMs | Constitutive | Ig fold proteins | Other CEACAMs |
| LAIR-1 | Broad on immune cells; on activation, upregulated on neutrophils and downregulated on T cells | Ig-like | ITIM | Collagen | Constitutive | — | OSCAR |
| LILRB1 (CD85j) | Neutrophil, monocyte, dendritic cell, and NK cell, upregulated on activation | Ig-like | ITIM | S100 proteins | Upon cell damage | — | TLR4, RAGE |
| LILRB3 (CD85a) | Neutrophil, monocyte, dendritic cell | Ig-like | ITIM | Unknown cytokeratin-associated ligand | Upon cell damage | Unknown in S. aureus (LTA shown for mice ortholog PIR-B) | TLR2/6 |
| PVR | Dendritic cell, upregulated on activation | Ig-like | ITIM | Nectin-3 | Constitutive | Poliovirus | — |
| Siglec 2, 3, 5–11 | Broad on immune cells, differs per receptor | Ig-like | ITIM | Sialic acids | Constitutive | Sialic acids | Siglec 14–16 |
| Siglec 2, 3, 5–11 | Broad on immune cells, differs per receptor | Ig-like | ITIM | Hsp70 | Upon cell damage | — | TLR4, RAGE |
| Siglec 10 | B cell, eosinophil, monocyte | Ig-like | ITIM | HMGB1, Hsp90 | Upon cell damage | — | TLR4, RAGE |
| SIRL-1 | Neutrophil, monocyte, downregulated on activation | Ig-like | ITIM | LL-37, S100 proteins | Upon cell damage and immune activation | Phenol-soluble modulins of Staphylococcus | TLR4, RAGE, FPR2 |
| TIGIT | T cell, NK cell, upregulated on activation | Ig-like | ITIM | DNAM-1, TIGIT | TIGIT upregulated on activation | Unknown in F. nucleatum | DNAM-1 |
| iPRR . | iPRR expression . | iPRR structure . | Signaling pathway . | Endogenous ligand . | Endogenous ligand expression . | Microbial ligand . | Activating receptor for the same ligand . |
|---|---|---|---|---|---|---|---|
| CD300a/f | Broad on immune cells, upregulated on activation | Ig-like | ITIM | PS, PE | Exposed in programmed cell death | — | Tim4 |
| CEACAM‑1 | Broad on immune, epithelial, and endothelial cells | Ig-like | ITIM | CEACAM1 and other CEACAMs | Constitutive | Ig fold proteins | Other CEACAMs |
| LAIR-1 | Broad on immune cells; on activation, upregulated on neutrophils and downregulated on T cells | Ig-like | ITIM | Collagen | Constitutive | — | OSCAR |
| LILRB1 (CD85j) | Neutrophil, monocyte, dendritic cell, and NK cell, upregulated on activation | Ig-like | ITIM | S100 proteins | Upon cell damage | — | TLR4, RAGE |
| LILRB3 (CD85a) | Neutrophil, monocyte, dendritic cell | Ig-like | ITIM | Unknown cytokeratin-associated ligand | Upon cell damage | Unknown in S. aureus (LTA shown for mice ortholog PIR-B) | TLR2/6 |
| PVR | Dendritic cell, upregulated on activation | Ig-like | ITIM | Nectin-3 | Constitutive | Poliovirus | — |
| Siglec 2, 3, 5–11 | Broad on immune cells, differs per receptor | Ig-like | ITIM | Sialic acids | Constitutive | Sialic acids | Siglec 14–16 |
| Siglec 2, 3, 5–11 | Broad on immune cells, differs per receptor | Ig-like | ITIM | Hsp70 | Upon cell damage | — | TLR4, RAGE |
| Siglec 10 | B cell, eosinophil, monocyte | Ig-like | ITIM | HMGB1, Hsp90 | Upon cell damage | — | TLR4, RAGE |
| SIRL-1 | Neutrophil, monocyte, downregulated on activation | Ig-like | ITIM | LL-37, S100 proteins | Upon cell damage and immune activation | Phenol-soluble modulins of Staphylococcus | TLR4, RAGE, FPR2 |
| TIGIT | T cell, NK cell, upregulated on activation | Ig-like | ITIM | DNAM-1, TIGIT | TIGIT upregulated on activation | Unknown in F. nucleatum | DNAM-1 |
OSCAR, osteoclast-associated Ig-like receptor; PVR, poliovirus receptor; RAGE, receptor for advanced glycation end products.